Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Preclinical Development of a Novel Zika Virus-like Particle Vaccine in Combination with Tetravalent Dengue Virus-like Particle Vaccines

14 Sept 2024

Abstract excerpt

Declared as a Public Health Emergency in 2016 by the World Health Organization (WHO), the Zika virus (ZIKV) continues to cause outbreaks that are linked to increased neurological complications. Transmitted mainly by Aedes mosquitoes, the virus is spread mostly amongst several tropical regions with the potential of territorial expansion due to environmental and ecological changes. The ZIKV envelope protein's...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Insect symbiosis and bacterial influences
Share to Mosquito-borne diseases and control
Share to Viral Infections and Vectors

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 39340083
DOI: 10.3390/vaccines12091053

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Preclinical Development of a Novel Zika Virus-like Particle Vaccine in Combination with Tetravalent Dengue Virus-like Particle VaccinesPMID 39340083Read ↗

Induction of systemic and mucosal immune response against Zika virus by vaccination with non-infectious chimeric VLPsSemantic proximity Read ↗

An Envelope-Modified Tetravalent Dengue Virus-Like-Particle Vaccine Has Implications for Flavivirus Vaccine DesignSemantic proximity Read ↗

Designing B‐ and T‐cell multi‐epitope based subunit vaccine using immunoinformatics approach to control Zika virus infectionSemantic proximity Read ↗

Rational Design of Zika Virus Subunit Vaccine with Enhanced EfficacySemantic proximity Read ↗

Validation of an engineered Zika virus-like particle vaccine candidate in a mosquito-mouse transmission modelSemantic proximity Read ↗

Immuno-informatics guided designing of a multi-epitope vaccine against Dengue and ZikaSemantic proximity Read ↗

Development of Zika Virus VaccinesSemantic proximity Read ↗

Chikungunya virus vaccine: a decade of progress solving epidemiological dilemma, emerging concepts, and immunological interventionsSemantic proximity Read ↗

An RNA nanoparticle vaccine against Zika virus elicits antibody and CD8+ T cell responses in a mouse modelSemantic proximity Read ↗

Zika virus-like particles bearing covalent dimer of envelope protein protect mice from lethal challengeSemantic proximity Read ↗

A Zika virus vaccine expressing premembrane-envelope-NS1 polyproteinSemantic proximity Read ↗

Virus-like particle vaccine with authentic quaternary epitopes protects against Zika virus-induced viremia and testicular damageSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.